Skip to main content

Table 3 Ratios significantly increased in BD patients without corticosteroid and immunosuppressant therapy compared with healthy controls and disease controls in both the discovery and validation sets

From: Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment

 

Discovery set BD-N vs.

Validation set: BD-N vs.

HC

HC

AAV

TA

p

fc

p

fc

p

fc

p

fc

TP/MCV

*

1.0579355

*

1.0712601

***

1.2863344

*

1.120872

PCT/MONO

**

1.425393

*

1.5778604

*

1.6435788

*

1.5614405

TP/MCH

**

1.0904052

*

1.1113632

***

1.2590039

*

1.0998654

TP/MCHC

**

1.0932365

**

1.1448527

***

1.2285696

*

1.091615

  1. * P < 0.05. ** P < 0.01. *** P < 0.001